Creating the future
of image-guided therapy

Image-guided therapy (IGT) is the practice of using medical imaging to plan, perform, and evaluate medical interventions. Such therapies not only make procedures more precise and less invasive for patients, but also generate rich streams of data for clinicians. Given the advances in processing power and artificial intelligence, there is immense potential to leverage this data to improve clinical outcomes. The INOVAIT network was founded by the Sunnybrook Research Institute in order to unlock the power of IGT data by facilitating the integration of AI data handling into the industry’s most promising ventures.


INOVAIT is a membership based national network with a strong industry focus that harnesses breakthroughs in image-guided therapy (IGT) and the power of digital systems, enhanced analytics, and artificial intelligence (AI) to advance medical imaging, diagnostics and deliver precision treatments.

By providing a platform to connect, educate, and invest in the sector’s brightest minds and most promising ventures, INOVAIT will grow Canada’s image-guided therapy industry into a global leader, ultimately improving patient outcomes and fueling economic development.

A radiologist reviews the brain scans of a patient.



Total Project Size (Million)

Experiential Training Opportunities

Explore Our Programs

INOVAIT provides its member institutions and partners with a comprehensive set of programs that are designed to maximize value creation and harness existing strength and diversity in image-guided therapy and artificial intelligence across Canada – from access to capital and training, to industry wide networking events.


Funding for collaborative R&D projects


Experiential training in image-guided therapy & artificial intelligence


Opportunity to meet industry professionals from across the country

healthcare researchers huddled around a digital screen
Become a member

Joining Canada’s first network in image-guided therapy and artificial intelligence connects you to a network of academic and industry leaders working together to advance the future of healthcare.

Upcoming Events


Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging

Tenomix, an image-guided diagnostic company based out of Western University’s BioNext Medtech Incubator, recently celebrated a significant milestone with an oversubscribed all-Canadian $2.14M funding round. Established in 2021 by four alums of WORLDiscoveries’ Medical Innovation Fellowship program at Western University, Tenomix is transforming cancer staging, particularly in colorectal cancer, with its innovative approach.

PulseMedica is laser-focused on tackling vitreoretinal diseases

The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.

Sonic Incytes is making liver screening more accessible 

Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).